(lp0
S"MiMedx Group stock surges 3% after first-quarter revenue beat MarketWatch - Apr 13, 2017 MiMedx Group Inc. MDXG, +8.48% shares surged 3% in premarket trade Thursday after the company's first-quarter revenue results beat the consensus.MiMedx Group Inc  Soars 8.48% on April 13 - Equities.comMIMEDX GROUP, INC.  Files An 8-K Results of Operations and ... - Market Exclusive"
p1
aS'MiMedx Group Inc  Breaks into New 52-Week High on April 17 Session Equities.com - 12 hours ago Shares of MiMedx Group Inc  broke into a new 52-week high yesterday, hitting a peak of $10.98. Shares closed at $10.80 after opening at $10.75 for a move of 0.56%.MiMedx Group, Inc.  Achieves New High - Aiken AdvocateMiMedx Group, Inc. closed with a change of 8.48% in the Previous Trading Session - Free Observer'
p2
aS"MiMedx Group  Catches Eye: Stock Jumps 8.5% in Session Nasdaq - 21 hours ago MiMedx Group, Inc.MDXG was a big mover last session, as its shares rose above 8% on the day. The move came after the company's first-quarter 2017 revenue performance exceeded the top end of its guidance, especially in light of the traditional ..."
p3
aS"The Use Of MiMedx Allografts From The Company's Multiple Product Families To ... PR Newswire  - Apr 5, 2017 MARIETTA, Ga., April 5, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market&nbsp;..."
p4
aS'MiMedx Group, Inc.  Makes It Very Clear Through These Technicals NY Stock News - 21 hours ago The technicals for MiMedx Group, Inc.  has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.'
p5
aS'Equity Check-in on Shares of MiMedx Group, Inc.  Baxter Review - 13 hours ago Investors may be focusing on Return on Invested Capital  information for MiMedx Group, Inc. . ROIC is a metric that can be used to assess the efficiency of a particular company at allocating controlled capital into investments that ...'
p6
aS'MiMedx To Present At The 16th Annual Needham Healthcare Conference PR Newswire  - Mar 24, 2017 MARIETTA, Ga., March 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market&nbsp;...'
p7
aS'MiMedx Group  Prelim. Q1 Revenue Tops Views StreetInsider.com - Apr 13, 2017 MiMedx Group, Inc. , the leading biopharmaceutical company developing and marketing regenerative biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today&nbsp;...'
p8
aS'MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors PR Newswire  - Mar 19, 2017 MARIETTA, Ga., March 19, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market&nbsp;...'
p9
aS'MiMedx Group Inc  Breaks into New 52-Week High on April 13 Session Equities.com - Apr 13, 2017 Shares of MiMedx Group Inc  broke into a new 52-week high yesterday, hitting a peak of $10.77. Shares closed at $10.74 after opening at $9.98 for a move of 8.48%.'
p10
a.